Dengue (Fièvre dengue, Dengue Fever, DF) résumée en 3 images DF virus isolation in cell culture …. 4 virus dengue responsables : DEN-1 à DEN-4 avec immunité croisée incomplète Copyright CDC La FD est une maladie épidémique DF est une maladie épidémique saisonnière DHF: une mal. émergente qu’on soigne de mieux en mieux Cas de DHF reportés au Vietnam de 1963 à 1998 Dengue Thailand DF: la mortalité globale est faible, < 2% DF : mortalité globale faible (Thaïlande) La DF est une maladie émergente (ou en progression épidémique) N° cas annuels DHF Thailande - Indonesie - Vietnam Copyright CDC DF maladie épidémique urbaine (Bangkok) DF :une maladie émergente (Brésil) Dengue Brésil : âge de survenue Aedes aegypti: le principal vecteur Aedès : le moustique à pattes tigrées pique en fin de journée www.fiocruz.br/ccs/ estetica/dengue.htm. Géographie de DF et Aedes aegypti Année 2000 Dengue : répartition géographique Cycle de la dengue : - tropical - selvatique - urbain - … et rural ? cycle moustique – virus – homme (1) Copyright CDC cycle moustique – virus – homme (2) 1. Virus transmitted to human in mosquito saliva 2. Virus replicates in target organs 3. Virus infects white blood cells and lymphatic tissues 4. Virus released and circulates in blood Copyright CDC cycle moustique – virus – homme (3) 5. Second mosquito ingests virus with blood 6. Virus replicates in mosquito midgut and other organs, infects salivary glands 7. Virus replicates in salivary glands Copyright CDC MANIFESTATIONS CLINIQUES DENGUE Infection par la Dengue Asymptômatique Fièvre indifférenciée (Syndrome viral) Symptômatique Fièvre eruptive et algique (Syndr. Dengue) Pas d’hémorragie Dengue classique DC Parfois avec hémorragie Fièvre Dengue Hémorragique Sans choc avec choc: DSS Dengue hémorragique DHF Warning Signs for Dengue Shock Copyright CDC DHF: évolution temporelle de paramètres clin-biol (+ 2 SD) Copyright CDC Éruption de DF Éruption de DF Éruption de DF DFclassique signes hémorragiques mineurs : gingivorragies FD : Purpura spontané Purpura provoqué : tourniquet test DHF : syndrome hémorragique www.med.sc.edu:85/ mhunt/arbo.htm. (photo C Hatz, ITS) DHF : épanchements séreux DHF : épanchements séreux Increased Probability of DHF Copyright CDC ELISA Test for Serologic Diagnosis Copyright CDC Temperature, Virus Positivity, and AntiDengue IgM, by Fever Day Copyright CDC Ig M/Ig G DENGUE RAPID TEST INTERPRETATION OF THE RESULTS CONT ROL C IgG IgM RES ULT Sero Negative CONT ROL C Pos. IgG Neg. IgM Neg. RES ULT Primary Infection CONT ROL CONT ROL C Pos. IgG Neg. IgM Pos. RES ULT Secondary Infection C Pos. IgG Pos. IgM Pos. RES ULT C Pos. IgG Pos. IgM Neg. Past or Secondary Infection Read the test results after 15 to 30 minutes. Negative results must be confirmed at 30 minutes. Dengue sérologie : - infect. Iaire - infect 2ndaire www.panbio.com.au/modules. php?name=Content&pa.... Volume replacement flow chart for patients with DHF grade I - II - Haemorrhagia. - Thrombocytopenia. - Hematocrit rise. Initiate intravenous therapy (IV) 6ml/kg/h crystalloid solution for 1 -2 hrs Improvement Reduce IV 5ml/kg/h Crystalloid solution for 1 - 2 hrs Further improvement Reduce IV 3ml/kg/h Crystalloid solution for 6-12 hrs Discontinue IV therapy after 24 hrs · · · No improvement Increase IV 10ml/kg/h crystalloid solution for 2 hrs Improvement Reduce IV 6ml/kg/h Crystalloid with further reduction to 3ml/kg/h Discontinue IV therapy after 24 - 48 hrs Improvement: Hematocrit falls, pules rate and blood pressure stable, urine output rises. No improvement: Hematocrit rises pulse rate rises, blood pressure falls below 20 mmHg, urine output falls. Unstable signs: Urine output falls, signs of shock appear. - No improvement - Unstable vital signs See V dume r e placement grade III (next) Volume replacement flow chart for patients with DHF grade III, IV - Unstable vital signs. - Urine output falls. - Signs of shock. Immediate, rapid volume replacement: Initiate IV therapy 15 ml/kg/h crystalloid Solution for 1 hr Improvement No improvement Oxygen IV therapy 10ml/kg/h Crystalloid solution for 1 - 2 hrs Further improvement IV therapy by crystalloid sol. 5ml/kg/h for 4 - 5 hrs Further improvement IV therapy by crystalloid sol. 3ml/kg/h for 5 - 6 hrs Discontinue IV therapy after 24 - 48 hrs IV colloid (dextran 40, plasma) 10 - 20 ml/kg/h for 1 - 2 hrs - No improvement Improvement IV colloid 5ml/kg/h for 2 - 3 hrs Establish central venous access and urinary catheter Improvement Hematocrit falls Blood transfusion (10ml/kg/h) if hematocrit still>35% Hematocrit rises IV colloid as bolus repeat if necessary Contrôle de la dengue (1): lutte anti-Aedes Lutte anti-Aedès : utiliser les larvicides www.niaid.nih.gov/.../ bugborne01/dengue.htm Larvicide le + employé = Abate (temephos) (organophosphoré) Exemples des gîtes larvaires Gîtes larvaires : enlever, nettoyer, entretenir, couvrir, mettre de l’abate… 12 WHO recommendations 1. Dengue fever (DF) is a serious viral disease transmitted by an Aedes mosquito; 2. DF occurs in 2 forms: Dengue fever (DF) and Dengue Haemorrhagic Fever (DHF) 3. DF is an acute viral disease affecting older children & adults, rarely fatal; 4. DHF more severe: bleeding - occasionally shock can be fatal, mostly in children; 5. Suspected subjects need early recognition and treatment of DHF : it can be lifesaving ; unless promptly & adequately treated, the patient may shock & die. 6. Severe abdominal pains, black stools, skin/nose/gums bleeding, sweating, cold skin are danger signs. If any one noticed, go to hospital & give fluids 7. Give nutritious food and fluids to drink to the patients incl. during transfer; 8. Dengue mosquitoes bite during the day; 9. Patient should use mosquito net or stay in screened room during the illness; 10. Screen your rooms for mosquitoes (or use mosquito nets / or repellent ); 11. Discard objects in which water collects (tin, can, coconut shell, etc. dont allow water to collect in pits around house. All stored water containers should be covered all the time. This will prevent breeding of Dengue mosquitoes 12. Doctors / health workers treating cases of DF should notify health authorities